Navigation Links
Device Master File for OncoSec Medical System Completed and Submitted to FDA
Date:10/20/2011

nt piece of that strategy. Moving forward, we will continue to demonstrate the value of our treatment approaches as our clinical studies begin."

OncoSec plans to initiate three Phase II clinical trials under physician sponsored INDs using the OncoSec Medical System to deliver DNA IL-12: OMS-I100 for the treatment of melanoma; OMS-I120 for the treatment of Merkel cell carcinoma; and OMS-I130 for the treatment of cutaneous T-cell lymphoma.

About OncoSec Medical Inc.

OncoSec Medical Incorporated (OTCBB: ONCS) develops novel OMS ElectroOncology™ therapies that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics. Targeted local delivery of these agents is designed to achieve selective destruction of cancerous tumors while sparing healthy normal tissue, resulting in improved functional, cosmetic and quality of life outcomes. These therapies have achieved validating safety and efficacy data in early and late stage clinical studies of over 400 cancer patients. OncoSec's clinical programs include three Phase II clinical trials for OMS ElectroImmunotherapy™. More information is available at www.oncosec.com. Additional information may also be found at OncoSec's Facebook, Twitter, and LinkedIn sites.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely f
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. U. of Md. Researchers to Develop Devices to Revolutionize Drug Research
2. New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation
3. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
4. MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients
5. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
6. New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
7. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
8. Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device
9. Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device
10. Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies
11. Device Blocking Stomach Nerve Signals Shows Promise in Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  AbbVie (NYSE: ... 3 GIFT-I study of its investigational, all-oral, interferon ... with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of the ... Japan . 1 GIFT-I evaluated genotype ... Japanese patients, with and without cirrhosis, who were ...
(Date:5/26/2015)... Calif. , May 26, 2015 Thoratec ... mechanical circulatory support therapies to save, support and restore ... Goldman Sachs 36 th Annual Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight time (5:00 p.m., Eastern Daylight Time). ...
(Date:5/26/2015)... , May 26, 2015  Amgen (NASDAQ: ... from the Phase 3 OPTiM study in the ... The data published in JCO , which ... American Society of Clinical Oncology (ASCO) in 2013 and ... in patients with unresected stage IIIB, IIIC or IV ...
Breaking Medicine Technology:AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6Thoratec Presentation At Goldman Sachs Healthcare Conference To Be Webcast 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8
(Date:5/27/2015)... (PRWEB) May 27, 2015 SIMpalm ... helped its client to launch an Android version for ... merchants to accept credit, debit and ACH payments on ... Google Play at: https://play.google.com/store/apps/details?id=com.simpalm.paymentgateway . The iOS version ... has been recently updated by SIMpalm. , Forte ...
(Date:5/27/2015)... Get Tested Coachella Valley , a ... of HIV, will recognize its most influential, passionate and ... Ambassador Awards, to be held on Twitter on June ... first for public health campaigns, the online awards ceremony ... influencers for breaking down stigma, spreading awareness and educating ...
(Date:5/27/2015)... According to research conducted by Dr. Huay-Zong ... Dallas some migraine patients have an increased likelihood of ... apparently also have some shared risk factors -- particularly ... a history of diabetes and/or smoking. Both conditions were ... in particular was less common in Hispanics. , ...
(Date:5/27/2015)... The Advanced Fertility Center of Chicago announces ... business to better serve the needs of couples in Chicagoland. ... on the Northwest side of the city at 4920 North ... by calling the Chicago office at (773) 794–1818. This ... of Chicago. The other 2 offices are in Gurnee ...
(Date:5/26/2015)... 27, 2015 Carey Danis & ... testosterone gel lawsuit . The suit pertains to AndroGel, ... was filed in late April 2015, and a court ... Illinois federal court in mid-May.¹ , Testosterone gel lawsuits ... the Northern District of Illinois. The multidistrict litigation (MDL) ...
Breaking Medicine News(10 mins):Health News:Forte Payment System Launches Android Version of Payment App 2Health News:Regional Public Health Campaign to Host 1st Annual YesGTCV Social Ambassador Awards 2Health News:Regional Public Health Campaign to Host 1st Annual YesGTCV Social Ambassador Awards 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 2Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 4Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2
... , THURSDAY, Sept. 29 (HealthDay News) -- One-quarter of American ... to new research from the U.S. Agency for Healthcare Research ... blood pressure, also known as hypertension, 29 percent were black ... federal agency noted in its Sept. 27 News and ...
... , THURSDAY, Sept. 29 (HealthDay News) -- Campus-wide smoking bans ... habit, new research suggests. The finding stems from a ... a ban and one without. "Although we haven,t pinpointed ... most to the positive changes in students, smoking rates, having ...
... DCThrough the identification of a gene,s impact on a ... continue to make progress in understanding the mechanics ... of white matter, known as myelination. The study, published ... of The Journal of Neuroscience , identified Sox17 ...
... might think, cancer and diabetes appear to have some biology in ... the Cell Press journal, Cell, a pathway that initially ... also influences the odds that mice develop or resist diabetes. ... Lin28b become more sensitive to insulin and less prone to diabetes ...
... , HOUSTON, Sept. 29, 2011 Hormone researchers at ... on providing long-term treatment options for diabetes, obesity and ... naturally occurring estrogen. They now believe that ... body functions in both females and males. While estradiol ...
... 28, 2011 - (BRONX, NY) - People taking oral steroids ... severe vitamin D deficiency, according to a study of more ... Albert Einstein College of Medicine of Yeshiva University. Their ... of Clinical Endocrinology and Metabolism, suggest that physicians should more ...
Cached Medicine News:Health News:1 in 4 U.S. Adults Treated for High Blood Pressure: Report 2Health News:Campus Smoking Bans May Help College Students Quit 2Health News:Children's National researchers make breakthrough in understanding white matter development 2Health News:Children's National researchers make breakthrough in understanding white matter development 3Health News:Diabetes and cancer: A shared biological basis 2Health News:UH researchers explain hormonal role in glucose and fat metabolism 2Health News:Oral steroids linked to severe vitamin D deficiency in nationwide study 2
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
MRI curette, 8.5" overall length....
15" overall length, 5" handle....
10" overall length, 5" handle....
Medicine Products: